DPHARMA | DUOPHARMA BIOTECH BHD
1.86 (0.54%)
T-O: 1.85 (08:59:00)
Last updated: 17:00
Fundamental 7.0
Technical 2.6
Total Score 9.6
Fundamental
iSaham Fundamental Trend
FCON: 0.65 | Sharpe Ratio: 0.42 | LTS: 7.5
Quarter Reports
Trailing Dividend
Financial Ratios
| EPS | 8.97 sen |
| Trailing PE (Sector Median: 23.8) | 27.7 |
| PEG | 1.44 |
| Altman Z | 1.3 |
| Beaver | 0.053 |
| Current Ratio | 2.33 |
| Debt-Equity (DE) Ratio | 0.79 |
| FCF Yield | -2.55 % |
| Revenue QoQ | 8.45 % |
| Revenue YoY | 1.22 % |
| Profit QoQ | 4.49 % |
| Profit YoY | 14.75 % |
| All-Time Profit Margin (Sector Median: 2.3) | 16.4 % |
| ROE (ROIC: 7.12) | 10.32 % |
| Dividend Per Share (DPS) | 6.5 sen |
| Dividend Yield (DY) | 3.49 % |
Fair Value
Weighted Average Fair Value: 2.22
| Discounted Cash Flow (DCF) 5% Growth | 0.86 |
| Discounted Cash Flow (DCF) 10% Growth | 1.14 |
| Relative Valuation | 1.6 |
| Average Analysts FV based on 4 rating(s), +52.7% | 2.84 |
| Graham Formula | 0.71 |
| Graham Number | 1.39 |
| Net Tangible Asset (NTA) | 0.87 | Consistent QR FV | N/APremium Access Only |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit | 15.39 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 461.63 |
| Expected Revenue (M) | 4254.63 |
| Expected Growth (%) | 31.0 |
Directors Share Purchases (Beta)
No transaction in the last 2 months.
Technical
Summary
Market Cap: 1751 M.
Number of Shares: 941 M.
Adjusted Float: 40.43%.
Stock highly correlated with
PHARMA (94%)
RGTBHD (93%)
SCOMNET (93%)
MENANG (92%)
Manipulation Indicator: Very hard to manipulate.
Sectors: Consumer Products, Healthcare, Pharmaceuticals, Technology, Budget 2021, Post MCO, Vaccine
Code: 7148
Website: http://duopharmabiotech.com/
Related Links: Bursa | Annual Report | Announcement
Top Shareholdings
Updated on 25-Mar-2020
| Shareholder | Value (M) |
|---|---|
| Permodalan Nasional Berhad | 590.59 |
| Employees Provident Fund Board | 106.3 |
| Amanah Saham Bumiputera | 55.8 |
| Billion Victory Sdn Bhd | 31.77 |
| Public Islamic Treasures Growth Fund | 13.41 |
| Norges Bank | 12.64 |
| Manulife Investment Shariah Progressfund | 12.55 |
| Kumpulan Wang Persaraan (Diperbadankan) | 9.5 |
| Principal Dali Opportunities Fund | 8.59 |
| Eastspring Investmentssmall-Cap Fund | 7.8 |
| Manulife Investment Progress Fund | 7.8 |
| Lembaga Tabung Haji | 7.48 |
| Affin Hwang Aiiman Asia (Ex Japan) Growth Fund | 6.26 |
| Amanah Saham Malaysia 3 | 5.79 |
| Tokio Marine Life Insurance Malaysia Bhd | 5.27 |
| Principal Islamic Small Cap Opportunities Fund | 5.08 |
| Affin Hwang Growth Fund | 4.53 |
| Ooi Keng Tan | 4.1 |
| CIMB-Principal Small Cap Fund | 3.99 |
| Petroliam Nasional Berhad | 3.92 |
| Gibraltar BSN Aggressive Fund | 3.69 |
| Affin Hwang Principled Growth Fund | 3.68 |
| Medical Fund | 3.45 |
| Credit Suisse | 3.44 |
| Amtotal Return | 3.28 |
| Hong Leong Assurance Berhad | 3.2 |
| Areca Equitytrust Fund | 3.07 |